Publicaciones (74) Publicaciones de EVA MARTINEZ PINILLA

2024

  1. Iron Dysregulation in Alzheimer’s Disease: LA-ICP-MS Bioimaging of the Distribution of Iron and Ferroportin in the CA1 Region of the Human Hippocampus

    Biomolecules, Vol. 14, Núm. 3

  2. Iron Dysregulation in Alzheimer’s Disease: LA-ICP-MS Bioimaging of the Distribution of Iron and Ferroportin in the CA1 Region of the Human Hippocampus

    Biomolecules, Vol. 14, Núm. 3, pp. 295

2023

  1. Apolipoprotein D as a Potential Biomarker in Neuropsychiatric Disorders

    International Journal of Molecular Sciences, Vol. 24, Núm. 21

  2. Estrategias para fomentar el aprendizaje ubicuo en la docencia práctica en microscopía

    Modalidades de aprendizaje para la innovación educativa

  3. One-way or two-way sweet link between theobromine and depression?

    BMC Psychiatry

  4. Sistema iCardioMonitor para el seguimiento de personas con diagnóstico de insuficiencia cardiaca

    La universidad que experimenta: El laboratorio EITL de la Universidad de Oviedo: innovación abierta y colaborativa frente a los desafíos del siglo XXI (Dykinson), pp. 5

  5. The adenosine A2A receptor in the basal ganglia: Expression, heteromerization, functional selectivity and signalling

    International Review of Neurobiology (Academic Press Inc.), pp. 49-71

  6. The olfactory Olfr-78/51E2 receptor interacts with the adenosine A2A receptor. Effect of menthol and 1,8-cineole on A2A receptor-mediated signaling

    Frontiers in Pharmacology, Vol. 14

2022

  1. Desarrollo de un chatbot para responder a las preguntas frecuentes en relación al funcionamiento de una asignatura

    Avances y desafíos para la transformación educativa

  2. Genetic Inactivation of Free Fatty Acid Receptor 3 Impedes Behavioral Deficits and Pathological Hallmarks in the APPswe Alzheimer’s Disease Mouse Model

    International Journal of Molecular Sciences, Vol. 23, Núm. 7

  3. Plant-derived compounds, vitagens, vitagenes and mitochondrial function

    PharmaNutrition

2021

  1. Antixoxidant supplements versus health benefits of brief/intermittent exposure to potentially toxic physical or chemical agents

    Current Issues in Molecular Biology, Vol. 43, Núm. 2, pp. 650-664

  2. Avieyamientu: alzheimer y Apo D

    Ciencies. Cartafueyos Asturianos de Ciencia y Teunoloxía: Revista de la Academia de la Llingua Asturiana, Núm. 11, pp. 48-73

  3. Cuprizone‐induced neurotoxicity in human neural cell lines is mediated by a reversible mitochondrial dysfunction: Relevance for demyelination models

    Brain Sciences, Vol. 11, Núm. 2, pp. 1-16

  4. Neuroprotective effect of apolipoprotein d in cuprizone-induced cell line models: A potential therapeutic approach for multiple sclerosis and demyelinating diseases

    International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-23

2020

  1. Adenosine a2a and a3 receptors are able to interact with each other. A further piece in the puzzle of adenosine receptor-mediated signaling

    International Journal of Molecular Sciences, Vol. 21, Núm. 14, pp. 1-14

  2. Expression of GPR55 and either cannabinoid CB1 or CB2 heteroreceptor complexes in the caudate, putamen, and accumbens nuclei of control, parkinsonian, and dyskinetic non-human primates

    Brain Structure and Function, Vol. 225, Núm. 7, pp. 2153-2164

  3. Expression of cannabinoid CB1R–GPR55 heteromers in neuronal subtypes of the Macaca fascicularis striatum

    Annals of the New York Academy of Sciences, Vol. 1475, Núm. 1, pp. 34-42

  4. Microbiota and Other Preventive Strategies and Non-genetic Risk Factors in Parkinson’s Disease

    Frontiers in Aging Neuroscience, Vol. 12

  5. Natural Compounds as Guides for the Discovery of Drugs Targeting G-Protein-Coupled Receptors

    Molecules (Basel, Switzerland), Vol. 25, Núm. 21